SAMANTHA WILD: Open Payments
NPI 1750734265 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 30 payments from 13 companies in 2025. Trend: 2023 $1,123 · 2024 $1,540 · 2025 $1,260
Food & beverage: $1,181Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $374 |
| Janssen Biotech, Inc. | 8 | $232 |
| Pharmacosmos Therapeutics Inc. | 2 | $149 |
| Lilly USA, LLC | 1 | $109 |
| Grifols USA, LLC | 2 | $106 |
| ADMA BioManufacturing LLC | 1 | $91 |
| Biogen, Inc. | 2 | $53 |
| Lundbeck LLC | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: NUCALA, TREMFYA, COSELA, OMVOH, Xembify, Leqembi, VYEPTI, BENLYSTA.
Industry payments across TX — which companies pay providers there.
